Tag Archives: TROV

Best Blue Chip Stocks To Invest In 2019

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; font: 13.0px Verdana; -webkit-text-stroke: #000000} span.s1 {font-kerning: none}

Dow 19,000 has a nice ring to it. And the iconic blue chip stock gauge is edging ever closer to that milestone.

After Mondays record-breaking day, when the Dow Jones industrial average, large-company Standard & Poors 500 stock index, tech-dominated Nasdaq composite and the small-cap Russell 2000 all closed at record levels at the same time for the first time since Dec. 31, 1999, the Dow is on the verge of making more headlines and getting a big shout outon the evening news.

.oembed-asset-link { border-bottom: 1px solid #e1e1e1; } .oembed-link-anchor { display: block; clear: both; } .oembed-link-thumbnail{ float: left; padding: 14px; } .oembed-link-thumbnail img { max-width: 78px; max-height: 60px; display: block; } p.oembed-link-title { font-size: 75%; color: #009BFF; margin: 0 14px; padding-top: 12px; font-weight:normal; text-align: left; line-height: 120%; } p.oembed-link-desc { font-size: 100%; color: #666; font-weight: normal; margin: 0 14px 14px 14px; font-family: ‘Futura Today Light’; text-align: left; line-height: 120%; }

USA TODAY

Best Blue Chip Stocks To Invest In 2019: Kinross Gold Corporation(KGC)

Advisors’ Opinion:

  • [By Monica Gerson]

    Kinross Gold Corporation (USA) (NYSE: KGC) is projected to post a quarterly loss at $0.01 per share on revenue of $808.09 million.

    Crocs, Inc. (NASDAQ: CROX) is expected to report its quarterly earnings at $0.05 per share on revenue of $265.90 million.

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Kinross Gold Corporation (USA) (NYSE: KGC) and Yamana Gold Inc. (USA) (NYSE: AUY).

  • [By Lee Jackson]

    Kinross Gold Corp. (NYSE: KGC) may be the stock that give investors the most amount of leverage on a gold rebound. Management reduced the company’s annual capital expenditures forecast to $1.45 billion from $1.6 billion, saving $180 million from its cost restructuring initiatives. Cancellation of its upcoming semiannual dividend payment to its shareholders will save $182 million per year. Kinross expects to produce gold at a cost of $1,000 to $1,200 an ounce this year. The Merrill Lynch target is $7.00, and the consensus target is $6.55. The dividend, which soon will be cancelled, has a yield of 2.9%.

  • [By Wayne Duggan]

    Citi also placed Neutral ratings on Goldcorp Inc. (USA) (NYSE: GG), Kinross Gold Corporation (USA) (NYSE: KGC) and Silver Standard Resources Inc. (USA) (NASDAQ: SSRI).

  • [By Matthew DiLallo]

    Another major long-term project is Norte Abierto, which is also a 50/50 JV in Chile — this time with Barrick Gold — on one of the largest gold-copper discoveries in South America. Goldcorp just brought this project into its portfolio in 2017 after buying outKinross Gold’s (NYSE:KGC) 25% stake as well as a 25% interest from Barrick Gold.

Best Blue Chip Stocks To Invest In 2019: Durect Corporation(DRRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.

  • [By Stephan Byrd]

    Algert Global LLC lifted its stake in Durect Co. (NASDAQ:DRRX) by 338.9% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 498,711 shares of the specialty pharmaceutical company’s stock after acquiring an additional 385,088 shares during the quarter. Algert Global LLC’s holdings in Durect were worth $1,067,000 as of its most recent SEC filing.

Best Blue Chip Stocks To Invest In 2019: MicroStrategy Incorporated(MSTR)

Advisors’ Opinion:

  • [By Chris Neiger]

    MicroStrategy (NASDAQ:MSTR) reported its first-quarter results on April 27, and the company saw its total revenue tick up by 1.3% year over year. Just as with the company’s fourth-quarter results, MicroStrategy’s management said foreign-currency headwinds continued to have a negative impact on the company’s overall sales.

  • [By Jim Robertson]

    Small cap Alarm.com Holdings would bethe leading platform for the intelligently connected property. Millions of people depend on Alarm.com Holdings technology to monitor and control their property from anywhere. Centered on security and remote monitoring, the Companys platform addresses a wide range of market needs and enables application-based control for a growing variety of Internet of Things (IoT) devices.Its security, video monitoring, intelligent automation and energy management solutions are available througha network of thousands of professional service providers in North America and around the globe. The Company went public in June 2015 as a spinoff from MicroStrategy Incorporated (NASDAQ: MSTR) with shares selling for $14 during the IPO.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on MicroStrategy (MSTR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Blue Chip Stocks To Invest In 2019: TrovaGene, Inc.(TROV)

Advisors’ Opinion:

  • [By Paul Ausick]

    TrovaGene Inc. (NASDAQ: TROV) dropped about 44% Friday to post a new 52-week low of $0.24 after closing at $0.43 on Thursday. Volume was around 12.5 million, about 20 times the daily average of around 650,000. The firm this morning priced an offering of 15 million shares and warrants to purchase up to another 15 million shares at $0.30 per unit.

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) was down, falling around 42 percent to $0.25. Trovagene priced its 15 million share common stock offering at $0.30 per share.

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) was down, falling around 40 percent to $0.26. Trovagene priced its 15 million share common stock offering at $0.30 per share.

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) shares dropped 27 percent to $1.27. Trovagene reported a Q4 loss of $8.5 million on revenue of $68,000. Piper Jaffray downgraded TrovaGene from Neutral to Underweight.

  • [By Lisa Levin]

    Shares of TrovaGene Inc (NASDAQ: TROV) were down 13 percent to $5.28. Trovagene reported a Q4 loss of $(0.26) per share.

    Sunrun Inc (NASDAQ: RUN) was down, falling around 13 percent to $6.22. Sunrun reported a Q4 loss of $(0.15) per share on revenue of $99.6 million.

Top Cheap Stocks To Watch For 2018

Here at Zacks, we don’t generally classify stocks as “cheap” or “expensive”, and rather than looking at the stock’s face value, we have a system that puts an emphasis on earnings estimate revisions to find stocks that will hopefully be winners for investors.

Source: Flickr

That being said, low-priced stocks can be attractive to smaller investors that can’t necessarily afford large stakes in companies with higher priced stocks.

Top Cheap Stocks To Watch For 2018: Petroleo Brasileiro S.A.- Petrobras(PBR)

Advisors’ Opinion:

  • [By Chris Lange]

    And Petroleo Brasileiro S.A. (NYSE: PBR), better known as Petrobras, is scheduled to release its most recent quarterly results Tuesday. The consensus estimates call for a net loss of $0.05 per share, as well as $18.05 million in revenue. Shares ended the weekat $8.91. The consensus price target is $11.22, and the 52-week range is $4.98 to $12.56.

  • [By Chris Lange]

    Short interest at Petroleo Brasileiro S.A. (NYSE: PBR), or Petrobras, decreased to 42.63 million shares from the previous 43.53 million. The stock traded at $9.06 a share, in a 52-week range of $5.19 to $12.56. Unfortunately, Petrobras may be trading on an entirely different set of fundamentals and sentiment due to its ongoing woes in Brazil.

  • [By Paul Ausick]

    Credit rating agency Standard & Poor’s on Friday raised its corporate credit rating on Petroleo Brasileiro S.A. (NYSE: PBR), commonly known as Petrobras, one notch, from B+ to BB-. The rating change does not lift Petrobras out of the non-investment grade category, but it lowers the risk from “highly speculative” to “speculative.”

  • [By Chris Lange]

    Short interest at Petroleo Brasileiro S.A. (NYSE: PBR), or Petrobras, increased to 34.35 million shares from the previous 31.85 million. The stock traded at $13.40 a share, in a 52-week range of $7.61 to $14.93. Unfortunately, Petrobras may be trading on an entirely different set of fundamentals and sentiment due to its ongoing woes in Brazil.

Top Cheap Stocks To Watch For 2018: Lowe’s Companies Inc.(LOW)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart for Lumber Liquidators Holdings showstabilization with a slight uptick over the past two years while large capsThe Home Depot, Inc (NYSE: HD)and Lowe’s Companies, Inc (NYSE: LOW) have been much more steady performers:

  • [By The Ticker Tape]

    Homebuilders like Lennar, PulteGroup, Inc. (NYSE: PHM), and D.R. Horton, Inc. (NYSE: DHI) could benefit from a strengthening housing recovery. If you’re bullish on housing, you might want to take a step back and think about other companies in that space. Home improvement stores like Home Depot Inc (NYSE: HD) and Lowe's Companies, Inc. (NYSE: LOW) could get a boost as well as companies that supply products for new homes like Whirlpool Corporation (NYSE: WHR) and USG Corporation(NYSE: USG).

  • [By Lisa Levin]

    Lowe's Companies, Inc. (NYSE: LOW) reported better-than-expected results for its third quarter.

    Lowe's reported Q3 earnings of $1.05 per share on revenue of $16.77 billion. However, analysts were expecting a profit of $1.03 per share on sales of $16.59 billion. Its comparable sales gained 5.7 percent during the quarter.

  • [By ]

    Technology is at the core of Home Depot’s (HD) continued growth, and it’s why the company announced today that it aims to hire another 1,000 tech professionals to help it pull even further away from rivals like Lowe’s (LOW) .

Top Cheap Stocks To Watch For 2018: TrovaGene, Inc.(TROV)

Advisors’ Opinion:

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) shares dropped 27 percent to $1.27. Trovagene reported a Q4 loss of $8.5 million on revenue of $68,000. Piper Jaffray downgraded TrovaGene from Neutral to Underweight.

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) was down, falling around 42 percent to $0.25. Trovagene priced its 15 million share common stock offering at $0.30 per share.

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) was down, falling around 40 percent to $0.26. Trovagene priced its 15 million share common stock offering at $0.30 per share.

  • [By Paul Ausick]

    TrovaGene Inc. (NASDAQ: TROV) dropped about 44% Friday to post a new 52-week low of $0.24 after closing at $0.43 on Thursday. Volume was around 12.5 million, about 20 times the daily average of around 650,000. The firm this morning priced an offering of 15 million shares and warrants to purchase up to another 15 million shares at $0.30 per unit.

Best Medical Stocks To Own Right Now

Scott Kicks Off Battle Over Senate Tax Bill Life Provisions

What Brighthouse Told Investors About Distribution

Senate Republicans to Add ACA Mandate Fight to Tax Fight

The Republican tax plans are suddenly looking a lot more like health care bills, with provisions that may affect coverage and increase medical expenses for millions of families.

The House version of the tax bill, which President Donald Trump endorsed on Tuesday, would end a deduction that allows families of disabled children and elderly people to write off large medical expenses. The Senate plan would repeal the Affordable Care Act requirement that most Americans carry insurance, a move that insurers promise would raise premiums in the nationwide individual insurance market.

The provisions would help offset the cost of large tax cuts for corporations and individuals. But the move has sparked a new wave of opposition from the health care industry and others who are concerned about its impact — the same political headwinds that tanked Republican efforts to repeal the Affordable Care Act earlier this year.

Best Medical Stocks To Own Right Now: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested shorting women’s health stock Juniper Pharmaceuticals (NASDAQ: JNP):

    Juniper Pharmaceuticals shares have yet to break under a key support level at $5.00. But, waiting until that happens may be too late. After some continued testing of that floor, if-and-when the support should break, the ensuing selloff could materialize in a hurry. If you’re not it at the time it happens, you may not be able to get in at a decent price.

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap women’s health therapeutic stock Juniper Pharmaceuticals (NASDAQ: JNP):

Best Medical Stocks To Own Right Now: Wyndham Worldwide Corp(WYN)

Advisors’ Opinion:

  • [By Lee Jackson]

    The chief financial officerat Wyndham Worldwide Corp. (NYSE: WYN) wasselling stock this past week. Thomas Conforti parted with 25,900 shares of the hotel giant at $82.41 apiece. The total for the trade was posted at $2 million. The shares closed Friday at $82.65. The 52-week range is $62.60 to $86.72, and the consensus price target is $90.

  • [By Lisa Levin]

    Wednesday afternoon, the cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Conn's Inc (NASDAQ: CONN) and Wyndham Worldwide Corporation (NYSE: WYN).

  • [By Travis Hoium]

    Shares of hotel brand Wyndham Worldwide Corporation (NYSE:WYN) jumped as much as 11.1% in trading Wednesday after reporting first-quarter 2017 earnings. At 3:45 p.m. EDT on Wall Street, shares were still up an impressive 9.6% on the day.

Best Medical Stocks To Own Right Now: TrovaGene, Inc.(TROV)

Advisors’ Opinion:

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) was down, falling around 42 percent to $0.25. Trovagene priced its 15 million share common stock offering at $0.30 per share.

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) was down, falling around 40 percent to $0.26. Trovagene priced its 15 million share common stock offering at $0.30 per share.

  • [By Lisa Levin]

    Shares of TrovaGene Inc (NASDAQ: TROV) were down 13 percent to $5.28. Trovagene reported a Q4 loss of $(0.26) per share.

    Sunrun Inc (NASDAQ: RUN) was down, falling around 13 percent to $6.22. Sunrun reported a Q4 loss of $(0.15) per share on revenue of $99.6 million.

  • [By Paul Ausick]

    TrovaGene Inc. (NASDAQ: TROV) dropped about 44% Friday to post a new 52-week low of $0.24 after closing at $0.43 on Thursday. Volume was around 12.5 million, about 20 times the daily average of around 650,000. The firm this morning priced an offering of 15 million shares and warrants to purchase up to another 15 million shares at $0.30 per unit.

Best Medical Stocks To Own Right Now: Synchronoss Technologies Inc.(SNCR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Synchronoss Technologies, Inc. (NASDAQ: SNCR) got a boost, shooting up 34 percent to $16.35. Synchronoss Technologies confirmed the receipt of indication of interest from Siris Capital Group to acquire all outstanding shares for $18 per share in cash.

  • [By Lisa Levin]

    Synchronoss Technologies, Inc. (NASDAQ: SNCR) shares dropped 39 percent to $10.27 after Siris Capital disclosed that it is no longer interested in an all cash takeover of the company. Synchronoss Technologies said that it continues to explore full range of alternatives, including sale.

  • [By Lisa Levin]

    In trading on Wednesday, financial shares fell 1.72 percent. Meanwhile, top losers in the sector included Whitestone REIT (NYSE: WSR), down 8 percent, and Synchronoss Technologies, Inc. (NASDAQ: SNCR), down 7 percent.

  • [By Jim Robertson]

    On Tuesday, our Elite Opportunity Pronewsletter suggested going long on small cap cloud software and services stock Synchronoss Technologies (NASDAQ: SNCR):

  • [By Paul Ausick]

    Synchronoss Technologies Inc. (NASDAQ: SNCR) posted a new 52-week low of $9.95 on Tuesday, down about 41% from Monday’s closing price of $16.75. The stock’s 52-week high is $49.94. Volume totaled around 19 million shares, about 20 times the daily average. The company said this morning that takeover talks by private equity firm Siris Capital Group had ended without an agreement.

Best Medical Stocks To Own Right Now: Logitech International S.A.(LOGI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Mad Catz Interactive, Inc. (USA) (NYSE: MCZ) shares were also up, gaining 35 percent to $0.260 as the company disclosed that it has sold its Saitek simulation product line to Logitech International SA (USA) (NASDAQ: LOGI) for $13 million in cash.

  • [By WWW.THESTREET.COM]

    For his “Executive Decision” segment, Cramer once again sat down with Bracken Darrell, president and CEO of Logitech (LOGI) , the computer accessory maker with shares that are up 27% since Cramer last checked in back in November.

Best Medical Stocks To Own Right Now: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.